🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Australia state records 1 virus case as some doctors oppose vaccine rollout

Published 13/01/2021, 12:06 pm
© Reuters.
AZN
-
PFE
-

By Swati Pandey

SYDNEY, Jan 13 (Reuters) - New South Wales, Australia's most populous state, recorded one local coronavirus case on Wednesday as the country's doctors sought to pause the rollout of the AstraZeneca COVID-19 vaccine, saying it may not be effective in establishing herd immunity.

The opposition to the vaccine casts a cloud over Australia's immunisation plans, as the AstraZeneca AZN.L jab is the centrepiece of the Australian government's immunisation plan, and 53 million doses are already on hand.

"The question is really whether it is be able to provide herd immunity. We are playing a long game here. We don't know how long that will take," said Professor Stephen Turner, the president of the Australian and NZ Society for Immunology.

Turner added that the government must pivot towards getting more of the Moderna and Pfizer (NYSE:PFE) vaccines. The concern stems from testing of the AstraZeneca vaccine, which some shown it to be less effective than the other two.

Australia has 10 million doses of the Pfizer PFE.N vaccine, though neither AstraZeneca nor Pfizer have approval from the country's drug regulator, the Therapeutic Goods Administration (TGA).

Australia's chief medical officer, Paul Kelly, attempted to thwart the concerns around its efficacy, telling the Australian Broadcasting Corp (ABC) the AstraZeneca jab was "effective", "safe" and of "high quality".

"The great advantage of the AstraZeneca vaccine is it's being made here in Australia," Kelly said. "It will be available as soon as the TGA gives its tick, which we expect that it will in February."

Kelly said Australia will have more data by February as well as "real-world information" coming from London, which has already rolled out the vaccine.

AstraZeneca did not immediately respond to an email request for comment.

Australia has been more successful than many other countries in managing the pandemic, with total infections in the country of 25 million people at about 28,600, with 909 deaths.(Graphic: https://tmsnrt.rs/34pvUyi)

Its success is largely attributable to border closings and widespread compliance with social-distancing rules, along with aggressive testing and tracing programmes.

Victoria and Queensland states recorded no community cases overnight.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Reuters COVID-19 tracker

https://tmsnrt.rs/34pvUyi)

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.